PT  - JOURNAL ARTICLE
AU  - Moreno, Anna Camille
AU  - Sikka, Sabrina K.
AU  - Thacker, Holly L.
TI  - Genitourinary syndrome of menopause in breast cancer survivors: Treatments are available
AID  - 10.3949/ccjm.85a.17108
DP  - 2018 Oct 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 760--766
VI  - 85
IP  - 10
4099  - http://www.ccjm.org/content/85/10/760.short
4100  - http://www.ccjm.org/content/85/10/760.full
SO  - Cleve Clin J Med2018 Oct 01; 85
AB  - When treating the genitourinary syndrome of menopause (GSM) in women with breast cancer or at high risk of breast cancer, clinicians must balance the higher cancer risks associated with hormonal treatments against the severity of GSM symptoms, which can be exacerbated by breast cancer treatments. Options for patients who need hormonal therapy include locally applied estrogens, dehydroepiandrosterone (DHEA), and estrogen receptor agonists/antagonists, which vary in their impact on breast cancer risk.